Oğuz Öztürk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Oğuz Öztürk has a total of 410 co-authors. Here are the top co-authors by number of shared publications:
- Mucahit Ergul
Department of Gastroenterology, Ankara Bilkent City Hospital, Ankara, Türkiye
8 shared publications - Yavuz Cagir
Department of Gastroenterology, Yenimahalle Training and Research Hospital, Ankara Yıldırım Beyazıt University, Ankara, Türkiye
7 shared publications - Ali Atay
Department of Gastroenterology, Ankara Bilkent City Hospital, Ankara, Türkiye
6 shared publications - Ilhami Yuksel
Department of Gastroenterology, Ankara Bilkent City Hospital, Ankara, Türkiye; Department of Gastroenterology, Ankara Yıldırım Beyazıt University School of Medicine, Ankara, Türkiye
6 shared publications - Emra Asfuroğlu Kalkan
Department of Internal Medicine, Ankara Bilkent City Hospital, 06800 Ankara, Türkiye
5 shared publications - Ihsan Ates
Department of Internal Medicine, Ankara Bilkent City Hospital, Ankara 06800, Türkiye
5 shared publications
Latest Publications
- Open Access
- 3 September 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 37 (10) , 1096-1098
Lumen-Apposing Metal Stent in the Treatment of Persistent Dysphagia due to Cervical Radiation Therapy
Cite this article as: Yilmaz E, Ergul M, Ozturk O, et al. Lumen-apposing metal stent in the treatment of persistent dysphagia due to cervical radiation therapy. Turk J Gastroenterol. Published online September 3, 2026. doi: 10.5152/tjg.2026.26290.
- 3 September 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 37 (10) , 1096-1098
Open AccessLumen-Apposing Metal Stent in the Treatment of Persistent Dysphagia due to Cervical Radiation Therapy
Cite this article as: Yilmaz E, Ergul M, Ozturk O, et al. Lumen-apposing metal stent in the treatment of persistent dysphagia due to cervical radiation therapy. Turk J Gastroenterol. Published online September 3, 2026. doi: 10.5152/tjg.2026.26290.
- Open Access
- 18 August 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 37 (9) , 1006-1009
Lumen-Apposing Metal Stent as a Salvage Therapy for Corrosive-Induced Gastric Outlet Obstruction: A Case Report
Cite this article as: Ergul M, Ozturk O, Ayte MR, et al. Lumen-apposing metal stent as a salvage therapy for corrosive-induced gastric outlet obstruction: A case report. Turk J Gastroenterol. Published online August 18, 2026. doi: 10.5152/tjg.2026.25719
- 18 August 2026
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 37 (9) , 1006-1009
Open AccessLumen-Apposing Metal Stent as a Salvage Therapy for Corrosive-Induced Gastric Outlet Obstruction: A Case Report
Cite this article as: Ergul M, Ozturk O, Ayte MR, et al. Lumen-apposing metal stent as a salvage therapy for corrosive-induced gastric outlet obstruction: A case report. Turk J Gastroenterol. Published online August 18, 2026. doi: 10.5152/tjg.2026.25719
- Open Access
Relationship of Renal Sinus Fat and Circadian Blood Pressure in Patients with Hepatosteatosis: A New Perspective from a Retrospective Study
Background and Objectives: Renal sinus fat accumulation affects many diabetic processes, including blood pressure. The aim of this study was to find out if there is a link between the amount of fat in the renal sinus and the blood pressure that changes throughout the day in adults with non-alcoholic fatty liver disease (NAFLD). Materials and Methods: This retrospective analysis involved 55 adult patients diagnosed with non-alcoholic fatty liver disease (NAFLD) based on abdominal computed tomography (CT) and who had undergone 24 h ambulatory blood pressure monitoring (ABPM). According to standard ABPM criteria, individuals whose night-time systolic blood pressure decreased by ≥10% compared to daytime values were classified as “dippers,” whereas those with a reduction of Results: The non-dipper group had a significantly higher leukocyte count (p = 0.012). Renal sinus fat volume (RSFV) was significantly larger in the non-dipper group (6.41 ± 3 mL) than the dipper group (4.12 ± 2.26 mL; p = 0.005). In the ROC curve analysis showing the role of RSFV in predicting the non-dipper blood pressure pattern, the threshold value for RSFV in our cohort was determined as ≥3.7 mL with a positive predictive value of 72.2%. Conclusions: Our findings indicated that RSFV plays a significant role in predicting the non-dipper blood pressure profile among individuals diagnosed with NAFLD. Participants with an RSFV of 3.7 mL or more in our cohort were more likely to exhibit a non-dipping blood pressure pattern. Future studies are needed to validate these findings in larger cohorts.
Open AccessRelationship of Renal Sinus Fat and Circadian Blood Pressure in Patients with Hepatosteatosis: A New Perspective from a Retrospective Study
Background and Objectives: Renal sinus fat accumulation affects many diabetic processes, including blood pressure. The aim of this study was to find out if there is a link between the amount of fat in the renal sinus and the blood pressure that changes throughout the day in adults with non-alcoholic fatty liver disease (NAFLD). Materials and Methods: This retrospective analysis involved 55 adult patients diagnosed with non-alcoholic fatty liver disease (NAFLD) based on abdominal computed tomography (CT) and who had undergone 24 h ambulatory blood pressure monitoring (ABPM). According to standard ABPM criteria, individuals whose night-time systolic blood pressure decreased by ≥10% compared to daytime values were classified as “dippers,” whereas those with a reduction of Results: The non-dipper group had a significantly higher leukocyte count (p = 0.012). Renal sinus fat volume (RSFV) was significantly larger in the non-dipper group (6.41 ± 3 mL) than the dipper group (4.12 ± 2.26 mL; p = 0.005). In the ROC curve analysis showing the role of RSFV in predicting the non-dipper blood pressure pattern, the threshold value for RSFV in our cohort was determined as ≥3.7 mL with a positive predictive value of 72.2%. Conclusions: Our findings indicated that RSFV plays a significant role in predicting the non-dipper blood pressure profile among individuals diagnosed with NAFLD. Participants with an RSFV of 3.7 mL or more in our cohort were more likely to exhibit a non-dipping blood pressure pattern. Future studies are needed to validate these findings in larger cohorts.
- Open Access
- 12 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (50) , e46562
Male predominance in inflammatory bowel disease despite similar disease activity: A large retrospective cohort study
Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn’s disease (CD), exhibit clinical heterogeneity, with sex-related differences potentially influencing disease course and prognosis. This study investigates the impact of sex on IBD prognosis in a large cohort. Data were collected from patients diagnosed with IBD at our clinics between July 1993 and April 2025. Demographic, clinical, and treatment variables were analyzed, focusing on sex-based differences in disease onset, disease activity, extraintestinal manifestations (EIMs), treatment escalation, hospitalizations, and surgical interventions. A total of 1774 patients diagnosed with IBD were included in the study. A male predominance (61%) was observed in IBD, with higher male-to-female ratios in both ulcerative colitis (1.6:1) and CD (1.47:1). Female patients presented earlier with IBD (mean age 34.7 vs 37.0 years; P = .001) and had a higher frequency of EIMs, particularly peripheral arthritis and erythema nodosum ( P < .001). No significant sex differences were observed in disease severity, hospitalizations, or need for treatment escalation. However, female patients with CD demonstrated higher disease activity at baseline, as measured by the Crohn’s disease activity index. Both sexes exhibited similar rates of biologic therapy use, the number of biologic therapies, hospitalizations, and major surgeries. Despite the male predominance in IBD prevalence, sex-related differences in clinical outcomes were minimal, with both sexes experiencing comparable disease activity, treatment escalation, and need for surgery. However, female patients exhibited a higher frequency of EIMs, highlighting the importance of a sex-based approach in clinical management.
- 12 December 2025
- Published by Wolters Kluwer Health in Medicine
- Vol. 104 (50) , e46562
Open AccessMale predominance in inflammatory bowel disease despite similar disease activity: A large retrospective cohort study
Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn’s disease (CD), exhibit clinical heterogeneity, with sex-related differences potentially influencing disease course and prognosis. This study investigates the impact of sex on IBD prognosis in a large cohort. Data were collected from patients diagnosed with IBD at our clinics between July 1993 and April 2025. Demographic, clinical, and treatment variables were analyzed, focusing on sex-based differences in disease onset, disease activity, extraintestinal manifestations (EIMs), treatment escalation, hospitalizations, and surgical interventions. A total of 1774 patients diagnosed with IBD were included in the study. A male predominance (61%) was observed in IBD, with higher male-to-female ratios in both ulcerative colitis (1.6:1) and CD (1.47:1). Female patients presented earlier with IBD (mean age 34.7 vs 37.0 years; P = .001) and had a higher frequency of EIMs, particularly peripheral arthritis and erythema nodosum ( P < .001). No significant sex differences were observed in disease severity, hospitalizations, or need for treatment escalation. However, female patients with CD demonstrated higher disease activity at baseline, as measured by the Crohn’s disease activity index. Both sexes exhibited similar rates of biologic therapy use, the number of biologic therapies, hospitalizations, and major surgeries. Despite the male predominance in IBD prevalence, sex-related differences in clinical outcomes were minimal, with both sexes experiencing comparable disease activity, treatment escalation, and need for surgery. However, female patients exhibited a higher frequency of EIMs, highlighting the importance of a sex-based approach in clinical management.
- Open Access
- 31 October 2025
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 37 (2) , 270-272
Endoscopic Management of a Rare Intraluminal Duodenal “Windsock” Diverticulum Causing Recurrent Pancreatitis
Cite this article as: Ozturk O, Cagir Y, Durak MB, Ergul M, Atay A, Yuksel I. Endoscopic management of a rare intraluminal duodenal “windsock” diverticulum causing recurrent pancreatitis. Turk J Gastroenterol. Published online October 31, 2025. doi:10.5152/ tjg.2025.25051.
- 31 October 2025
- Published by AVES YAYINCILIK A.Ş. in Turkish Journal of Gastroenterology
- Vol. 37 (2) , 270-272
Open AccessEndoscopic Management of a Rare Intraluminal Duodenal “Windsock” Diverticulum Causing Recurrent Pancreatitis
Cite this article as: Ozturk O, Cagir Y, Durak MB, Ergul M, Atay A, Yuksel I. Endoscopic management of a rare intraluminal duodenal “windsock” diverticulum causing recurrent pancreatitis. Turk J Gastroenterol. Published online October 31, 2025. doi:10.5152/ tjg.2025.25051.
- 30 September 2025
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 78 (3) , 245-257
Post-ERCP Pancreatitis and Serum Asprosin: A Potential Marker Associated with Beta Cell Damage
Aim: Asprosin is a protein produced by adipose tissue that has a significant function in regulating glucose metabolism. Inflammation in pancreatitis leads to beta cell damage and deterioration of beta cell functions. Recent studies have shown a relationship between asprosin and pancreatic beta cell damage. This research aimed to examine the association between pancreatitis developing after endoscopic retrograde cholangiopancreatography (ERCP) and asprosin levels, which is also considered an indicator of beta cell damage. Materials and Methods: The study was conducted with 25 patients who developed pancreatitis after ERCP and 21 participants as a control group at Ankara Bilkent City Hospital. Acute pancreatitis was diagnosed through correlation of clinical, imaging, and laboratory findings. In addition, the post-ERCP pancreatitis group was classified as “mild” and “moderate-severe” according to disease severity, and asprosin levels were compared between the groups. Correlations between asprosin and biochemical and hematological parameters were analyzed. Results: Serum asprosin concentrations were elevated in the post-ERCP pancreatitis group (p < 0,001). Amylase, lipase, GGT, AST, total and direct bilirubin levels also increased significantly in the pancreatitis group. In the pancreatitis group, a negative correlation was observed between asprosin levels and leukocyte (r = -0.433; p = 0.031) and lymphocyte counts (r = -0.440; p = 0.028). No meaningful correlation was observed between asprosin concentrations and the severity of pancreatitis (p = 0,347). Conclusion: In patients with post-ERCP pancreatitis, asprosin levels are increased, which could potentially be associated with the inflammatory response. However, asprosin does not seem to directly reflect disease severity. Therefore, asprosin can be considered as a new biomarker candidate associated with pancreatic beta cell damage and inflammation; however, Additional research is required to elucidate its diagnostic and prognostic role.
- 30 September 2025
- Published by Ankara University in Ankara Üniversitesi Tıp Fakültesi Mecmuası
- Vol. 78 (3) , 245-257
Post-ERCP Pancreatitis and Serum Asprosin: A Potential Marker Associated with Beta Cell Damage
Aim: Asprosin is a protein produced by adipose tissue that has a significant function in regulating glucose metabolism. Inflammation in pancreatitis leads to beta cell damage and deterioration of beta cell functions. Recent studies have shown a relationship between asprosin and pancreatic beta cell damage. This research aimed to examine the association between pancreatitis developing after endoscopic retrograde cholangiopancreatography (ERCP) and asprosin levels, which is also considered an indicator of beta cell damage. Materials and Methods: The study was conducted with 25 patients who developed pancreatitis after ERCP and 21 participants as a control group at Ankara Bilkent City Hospital. Acute pancreatitis was diagnosed through correlation of clinical, imaging, and laboratory findings. In addition, the post-ERCP pancreatitis group was classified as “mild” and “moderate-severe” according to disease severity, and asprosin levels were compared between the groups. Correlations between asprosin and biochemical and hematological parameters were analyzed. Results: Serum asprosin concentrations were elevated in the post-ERCP pancreatitis group (p < 0,001). Amylase, lipase, GGT, AST, total and direct bilirubin levels also increased significantly in the pancreatitis group. In the pancreatitis group, a negative correlation was observed between asprosin levels and leukocyte (r = -0.433; p = 0.031) and lymphocyte counts (r = -0.440; p = 0.028). No meaningful correlation was observed between asprosin concentrations and the severity of pancreatitis (p = 0,347). Conclusion: In patients with post-ERCP pancreatitis, asprosin levels are increased, which could potentially be associated with the inflammatory response. However, asprosin does not seem to directly reflect disease severity. Therefore, asprosin can be considered as a new biomarker candidate associated with pancreatic beta cell damage and inflammation; however, Additional research is required to elucidate its diagnostic and prognostic role.
- Open Access
- 23 September 2025
- Published by MediHealth Academy in Intercontinental Journal of Emergency Medicine
- Vol. 3 (3) , 52-57
FGF-21 as a potential biomarker for coronary artery calcification: a non-invasive approach
Aims: The aim of this study was to investigate the relationship between fibroblast growth factor 21 (FGF-21) levels and coronary artery calcium (CAC) scores calculated using the Agatston method, and to evaluate the potential of FGF-21 as a non-invasive biomarker for the assessment of coronary artery calcification. Methods: A total of 54 adult individuals who had undergone coronary CT angiography within the past three months solely for cardiovascular risk assessment were prospectively included in the study. Serum FGF-21 levels were measured using the ELISA method, and CAC scores were determined via the Agatston scoring system. The relationship between FGF-21 levels and CAC scores was analyzed using Spearman’s correlation test. Results: A significant and strong positive correlation was observed between FGF-21 levels and CAC scores (r = 0.725, p < 0.001). Diabetes mellitus and hyperlipidemia were significantly associated with higher CAC scores (p = 0.006 and p = 0.024, respectively), whereas their associations with FGF-21 levels were not statistically significant (p = 0.065 and p = 0.104). No significant correlations were found between FGF-21 levels and other variables such as age, gender, hypertension, or biochemical parameters. Conclusion: The findings suggest that serum FGF-21 levels may be associated with coronary artery calcification and could serve as a non-invasive and easily applicable biomarker in individuals for coronary artery disease. FGF-21 may be particularly useful in clinical settings where access to advanced imaging modalities is limited.
- 23 September 2025
- Published by MediHealth Academy in Intercontinental Journal of Emergency Medicine
- Vol. 3 (3) , 52-57
Open AccessFGF-21 as a potential biomarker for coronary artery calcification: a non-invasive approach
Aims: The aim of this study was to investigate the relationship between fibroblast growth factor 21 (FGF-21) levels and coronary artery calcium (CAC) scores calculated using the Agatston method, and to evaluate the potential of FGF-21 as a non-invasive biomarker for the assessment of coronary artery calcification. Methods: A total of 54 adult individuals who had undergone coronary CT angiography within the past three months solely for cardiovascular risk assessment were prospectively included in the study. Serum FGF-21 levels were measured using the ELISA method, and CAC scores were determined via the Agatston scoring system. The relationship between FGF-21 levels and CAC scores was analyzed using Spearman’s correlation test. Results: A significant and strong positive correlation was observed between FGF-21 levels and CAC scores (r = 0.725, p < 0.001). Diabetes mellitus and hyperlipidemia were significantly associated with higher CAC scores (p = 0.006 and p = 0.024, respectively), whereas their associations with FGF-21 levels were not statistically significant (p = 0.065 and p = 0.104). No significant correlations were found between FGF-21 levels and other variables such as age, gender, hypertension, or biochemical parameters. Conclusion: The findings suggest that serum FGF-21 levels may be associated with coronary artery calcification and could serve as a non-invasive and easily applicable biomarker in individuals for coronary artery disease. FGF-21 may be particularly useful in clinical settings where access to advanced imaging modalities is limited.
- Open Access
- 17 September 2025
- Published by Academician Publishing
Gastroenteroloji Textbook - Cilt (1-2)
- 17 September 2025
- Published by Academician Publishing
Open AccessGastroenteroloji Textbook - Cilt (1-2)
- Open Access
- 17 September 2025
- Published by Academician Publishing
- p. 1-12
Gastroenterolojide Fizik Muayene
Fizik muayene, gastrointestinal hastalıkların tanı ve tedavisinde kritik bir öneme haizdir. Organ fonksiyonları ve patolojileri hakkında değerli bilgiler sunmakla beraber, inflamatuar bağırsak hastalıklar ve gastrointestinal kanama gibi altta yatan patolojilerin teşhisinde önemli role sahiptir. Hepatolojide fizik muayene, ileri tetkiklere başvurulup başvurulmaması yönünde yol gösterici olmanın yanında hastalığın seyrini ve tedaviye cevabın izlemi konusunda da önemli katkılar sunar. Bu bilgiler ışığında, klinisyenlerin ve gastroenterologların fizik muayenede yetkin olması son derece elzem olup; tanısal açıdan kritik bilgiler sunarak girişimsel işlemlere olan gereksinimi azaltabilir ve hastaya gereksiz işlem yapılmasının veya zarar verilmesinin önüne geçebilir. Kapsamlı bir genel fizik muayene; hastanın genel durumunu, beslenme durumunu ve yaşamsal belirtilerini bütüncül bir gözle değerlendirir. Bu süreçte gözlemlenen bulgular, örneğin ciltte soluklukla kendini gösteren anemi veya karaciğer işlev bozukluğunu düşündüren sarılık, potansiyel altta yatan sorunlara dair önemli ipuçları sunabilir. Abdomen muayenesinde ise inspeksiyon, palpasyon, perküsyon ve oskültasyon gibi temel yöntemler kullanılır. Bu sayede bağırsak sesleri, karaciğerin boyutu ve asit varlığı değerlendirilebilir. Bağırsak seslerinin yokluğu ileus veya obstrüksiyon gibi patolojileri akla getirir. Karaciğerin palpasyonu ile hepatomegali ve hassasiyet gibi bulgular elde edilebilir; bu da hepatit veya siroz gibi hastalıkların tanısı için önemlidir. Öte yandan, sarılık, spider anjiyomları ve palmar eritem gibi klinik bulgular, kronik karaciğer rahatsızlıklarını ortaya koyan değerli göstergelerdir. Ayrıca splenomegali, asit ve portal hipertansiyonun diğer belirtileri gibi ek bulguların varlığı da hastalığın prognozu hakkında fikir verebilir. Fizik muayenede düzenli aralıklarla takip edilen bu bulgular, hastalığın ilerleyişini izlemede ve uygulanan tedavinin etkinliğini değerlendirmede hayati rol oynamaktadır. Laboratuvar ve radyoloji sonuçlarıyla birlikte bir potada eritilen fizik muayene bulguları, hastanın durumuna ilişkin bütüncül ve derinlemesine bir değerlendirme sağlamaktadır.
- 17 September 2025
- Published by Academician Publishing
- p. 1-12
Open AccessGastroenterolojide Fizik Muayene
Fizik muayene, gastrointestinal hastalıkların tanı ve tedavisinde kritik bir öneme haizdir. Organ fonksiyonları ve patolojileri hakkında değerli bilgiler sunmakla beraber, inflamatuar bağırsak hastalıklar ve gastrointestinal kanama gibi altta yatan patolojilerin teşhisinde önemli role sahiptir. Hepatolojide fizik muayene, ileri tetkiklere başvurulup başvurulmaması yönünde yol gösterici olmanın yanında hastalığın seyrini ve tedaviye cevabın izlemi konusunda da önemli katkılar sunar. Bu bilgiler ışığında, klinisyenlerin ve gastroenterologların fizik muayenede yetkin olması son derece elzem olup; tanısal açıdan kritik bilgiler sunarak girişimsel işlemlere olan gereksinimi azaltabilir ve hastaya gereksiz işlem yapılmasının veya zarar verilmesinin önüne geçebilir. Kapsamlı bir genel fizik muayene; hastanın genel durumunu, beslenme durumunu ve yaşamsal belirtilerini bütüncül bir gözle değerlendirir. Bu süreçte gözlemlenen bulgular, örneğin ciltte soluklukla kendini gösteren anemi veya karaciğer işlev bozukluğunu düşündüren sarılık, potansiyel altta yatan sorunlara dair önemli ipuçları sunabilir. Abdomen muayenesinde ise inspeksiyon, palpasyon, perküsyon ve oskültasyon gibi temel yöntemler kullanılır. Bu sayede bağırsak sesleri, karaciğerin boyutu ve asit varlığı değerlendirilebilir. Bağırsak seslerinin yokluğu ileus veya obstrüksiyon gibi patolojileri akla getirir. Karaciğerin palpasyonu ile hepatomegali ve hassasiyet gibi bulgular elde edilebilir; bu da hepatit veya siroz gibi hastalıkların tanısı için önemlidir. Öte yandan, sarılık, spider anjiyomları ve palmar eritem gibi klinik bulgular, kronik karaciğer rahatsızlıklarını ortaya koyan değerli göstergelerdir. Ayrıca splenomegali, asit ve portal hipertansiyonun diğer belirtileri gibi ek bulguların varlığı da hastalığın prognozu hakkında fikir verebilir. Fizik muayenede düzenli aralıklarla takip edilen bu bulgular, hastalığın ilerleyişini izlemede ve uygulanan tedavinin etkinliğini değerlendirmede hayati rol oynamaktadır. Laboratuvar ve radyoloji sonuçlarıyla birlikte bir potada eritilen fizik muayene bulguları, hastanın durumuna ilişkin bütüncül ve derinlemesine bir değerlendirme sağlamaktadır.
- Open Access
- 29 June 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (13) , 4599
Assessing ChatGPT-v4 for Guideline-Concordant Inflammatory Bowel Disease: Accuracy, Completeness, and Temporal Drift
Background/Objectives: Chat Generative Pretrained Transformer (ChatGPT) is a useful resource for individuals working in the healthcare field. This paper will include descriptions of several ways in which ChatGPT-4 can achieve greater accuracy in its diagnosis and treatment plans for ulcerative colitis (UC) and Crohn’s disease (CD) by following the guidelines set out by the European Crohn’s and Colitis Organization (ECCO). Methods: The survey, which comprised 102 questions, was developed to assess the precision and consistency of respondents’ responses regarding the UC and CD. The questionnaire incorporated true/false and multiple-choice questions, with the objective of simulating real-life scenarios and adhering to the ECCO guidelines. We employed Likert scales to assess the responses. The inquiries were put to ChatGPT-4 on the initial day, the 15th day, and the 180th day. Results: The 51 true or false items demonstrated stability over a six-month period, with an initial accuracy of 92.8% at baseline, 92.8% on the 15th day, and peaked to 98.0% on the 180th day. This finding suggests a negligible effect size. The accuracy of the multiple-choice questions was initially 90.2% on Day 1, reached its highest point at 92.2% on Day 15, and then decreased to 84.3% on Day 180. However, the reliability of the data was found to be suboptimal, and the impact was deemed negligible. A modest, transient increase in performance was observed at 15 days, which subsequently diminished by 180 days, resulting in negligible effect sizes. Conclusions: ChatGPT-4 demonstrates potential as a clinical decision support system for UC and CD, but its assessment is marked by temporal variability and the inconsistent execution of various tasks. Essential initiatives that should be carried out before involving artificial intelligence (AI) technology in IBD trials are routine revalidation, multi-rater comparisons, prompt standardization, and the cultivation of a comprehensive understanding of the model’s limitations.
- 29 June 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (13) , 4599
Open AccessAssessing ChatGPT-v4 for Guideline-Concordant Inflammatory Bowel Disease: Accuracy, Completeness, and Temporal Drift
Background/Objectives: Chat Generative Pretrained Transformer (ChatGPT) is a useful resource for individuals working in the healthcare field. This paper will include descriptions of several ways in which ChatGPT-4 can achieve greater accuracy in its diagnosis and treatment plans for ulcerative colitis (UC) and Crohn’s disease (CD) by following the guidelines set out by the European Crohn’s and Colitis Organization (ECCO). Methods: The survey, which comprised 102 questions, was developed to assess the precision and consistency of respondents’ responses regarding the UC and CD. The questionnaire incorporated true/false and multiple-choice questions, with the objective of simulating real-life scenarios and adhering to the ECCO guidelines. We employed Likert scales to assess the responses. The inquiries were put to ChatGPT-4 on the initial day, the 15th day, and the 180th day. Results: The 51 true or false items demonstrated stability over a six-month period, with an initial accuracy of 92.8% at baseline, 92.8% on the 15th day, and peaked to 98.0% on the 180th day. This finding suggests a negligible effect size. The accuracy of the multiple-choice questions was initially 90.2% on Day 1, reached its highest point at 92.2% on Day 15, and then decreased to 84.3% on Day 180. However, the reliability of the data was found to be suboptimal, and the impact was deemed negligible. A modest, transient increase in performance was observed at 15 days, which subsequently diminished by 180 days, resulting in negligible effect sizes. Conclusions: ChatGPT-4 demonstrates potential as a clinical decision support system for UC and CD, but its assessment is marked by temporal variability and the inconsistent execution of various tasks. Essential initiatives that should be carried out before involving artificial intelligence (AI) technology in IBD trials are routine revalidation, multi-rater comparisons, prompt standardization, and the cultivation of a comprehensive understanding of the model’s limitations.